ZHEJIANG HAISEN PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.26 CNY | +0.66% |
|
-6.00% | -12.97% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 423M 58.58M | Sales 2023 | 397M 55.07M | Capitalization | 2.99B 414M |
|---|---|---|---|---|---|
| Net income 2022 | 108M 14.96M | Net income 2023 | 105M 14.55M | EV / Sales 2022 * | - |
| Net cash position 2022 | 246M 34.14M | Net cash position 2023 | 944M 131M | EV / Sales 2023 | 5.15 x |
| P/E ratio 2022 * |
-
| P/E ratio 2023 |
26.2
x | Employees | 636 |
| Yield 2022 * |
-
| Yield 2023 |
1.14% | Free-Float | 24.1% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.66% | ||
| 1 week | -6.00% | ||
| Current month | +2.71% | ||
| 1 month | +20.69% | ||
| 3 months | +23.34% | ||
| 6 months | -18.63% | ||
| Current year | -12.97% |
1 week
37.93
40.40
1 month
29.8542.16
Current year
26.5545.00
1 year
26.5556.99
3 years
26.5588.83
5 years
26.5588.83
10 years
26.5588.83
| Managers | Title | Age | Since |
|---|---|---|---|
Lin Ai
CEO | Chief Executive Officer | 63 | 11-06-30 |
Ai Juan Pan
DFI | Director of Finance/CFO | 62 | 98-01-31 |
Chuang Fan Wei
CHM | Chairman | 65 | 98-02-28 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Gang Zheng
BRD | Director/Board Member | 49 | 20-09-27 |
Gui Rong Fang
BRD | Director/Board Member | 48 | 20-09-27 |
Wen Tao Dai
BRD | Director/Board Member | 53 | 20-09-27 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-16 | 38.26 | +0.66% | 518,110 |
| 24-05-15 | 38.01 | -1.81% | 772,954 |
| 24-05-14 | 38.71 | -0.90% | 1,049,660 |
| 24-05-13 | 39.06 | +0.41% | 1,054,250 |
| 24-05-10 | 38.9 | -2.92% | 1,729,845 |
End-of-day quote Shenzhen S.E., May 15, 2024
More quotes
Zhejiang Haisen Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production and sales of chemical active pharmaceutical ingredient (APIs) and intermediates. The Company's main drugs include digestive system drugs, antipyretic and analgesic drugs, cardiovascular APIs, antidepressants drugs, antibacterial APIs, antiviral drugs, non-steroidal anti-inflammatory and other specialty APIs and preparations. The Company mainly conducts its businesses in domestic and overseas markets.
Sector
Pharmaceuticals
Calendar
02:00am
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -12.97% | 358M | |
| +32.36% | 709B | |
| +30.77% | 595B | |
| -1.60% | 367B | |
| +20.07% | 334B | |
| +6.04% | 289B | |
| +14.77% | 239B | |
| +9.13% | 211B | |
| -3.97% | 203B | |
| +9.27% | 171B |
- Stock Market
- Equities
- 001367 Stock